AN2 Therapeutics Inc (ANTX)

NASDAQ
20.66
-0.42(-1.99%)
  • Volume:
    15,977
  • Day's Range:
    20.27 - 21.35
  • 52 wk Range:
    6.88 - 23.58

ANTX Overview

Prev. Close
21.08
Day's Range
20.27-21.35
Revenue
-
Open
21.35
52 wk Range
6.88-23.58
EPS
-5.45
Volume
15,977
Market Cap
409.01M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
61,759
P/E Ratio
-3.55
Beta
-
1-Year Change
-
Shares Outstanding
19,402,658
Next Earnings Date
Nov 30, 2022
What is your sentiment on AN2 Therapeutics?
or
Vote to see community's results!

AN2 Therapeutics Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

AN2 Therapeutics Inc Company Profile

AN2 Therapeutics Inc Company Profile

Employees
22

AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menlo Park, California.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyBuyBuyStrong Buy
Technical IndicatorsNeutralSellStrong SellStrong BuyBuy
SummaryNeutralNeutralNeutralStrong BuyStrong Buy